Читать книгу The Advanced Practice Registered Nurse as a Prescriber - Группа авторов - Страница 13

1 Kaplan, L., & Brown, M.A. (2004). Prescriptive authority and barriers to NP practice. Nurse Practitioner, 29(3), 28–35.

2 Kaplan, L., & Brown, M.A. (2007). The transition of nurse practitioners to changes in prescriptive authority. Journal of Nursing Scholarship, 39(2), 184–190.

3 Kaplan, L., & Brown, M.A. (2009). Prescribing controlled substances: Perceptions, realities and experiences in Washington State. American Journal for Nurse Practitioners, 12(3), 44–51, 53.

4 Kaplan, L., Brown, M.A., Andrilla, H., & Hart, L.G. (2006). Barriers to autonomous practice. The Nurse Practitioner, 31(1), 57–63.

5 Kaplan, L., Brown, M.A., & Donohue, J.S. (2010). Prescribing controlled substances: How NPs in Washington are making a difference. The Nurse Practitioner, 35(5), 47–53.

6 National Organization of Nurse Practitioner Faculties. (2016). Criteria for evaluation of nurse practitioner programs. Retrieved from https://cdn.ymaws.com/www.nonpf.org/resource/resmgr/docs/evalcriteria2016final.pdf. (Accessed 7 September 2020.)

7 Phillips, S.J. (2020). 32nd annual APRN legislative update: Improving access to high‐quality, safe and effective healthcare. The Nurse Practitioner, 45(1), 28–55.

8 The IQVIA Institute. (2019). Medicine use and spending in the U.S. Retrieved from https://www.iqvia.com/insights/the‐iqvia‐institute/reports/medicine‐use‐and‐spending‐in‐the‐us‐a‐review‐of‐2018‐and‐outlook‐to‐2023. (Accessed 7 September 2020.)